HI-6 Dimethanesulfonate (DMS) and Atropine Sulfate Reconstitution Autoinjector Device (RAD) Feasibility Assessment
Solicitation number W6369-26-A112
Publication date
Closing date and time 2026/06/16 14:00 EDT
Last amendment date
Description
The Department of National Defence (DND), specifically the Canadian Forces Health Services
(CFHS), has a requirement for the services of a Contractor to test and evaluate the feasibility of
manufacturing HI-6 DMS and atropine sulfate drug products in a reconstitution autoinjector device
(RAD).
The scope of this requirement is to conduct a feasibility assessment using an existing prototype
of a RAD with the configuration of HI-6 DMS in the dry chamber (500 mg +/- 25%) and 1 mL
atropine (2 mg/mL) in the liquid chamber.
The work will involve the following:
• Project Management.
• Analytical Method Development.
• Material Processing and Performance Assessments.
• Mixing and Drug Delivery Model.
• Sterilization Impact Assessment.
Contract duration
The estimated contract period will be 12 month(s).
Trade agreements
-
Please refer to tender description or tender documents
Reason for limited tendering
A contracting officer can use limited tendering for specific reasons outlined in the applicable trade agreements. The reason for this contract is described below:
-
Exclusive Rights
Partner with another business
Are you interested in partnering with other businesses for this opportunity? Add your company to the list of businesses who are interested in partnering.
This list does not replace or affect the tendering procedures for this procurement process. Businesses are still required to respond to bid solicitations, and to compete based on the set criteria. For more information please read the Terms of use.
Contact information
Contracting organization
- Organization
-
Department of National Defence (DND)
- Address
-
101 Colonel By Drive
Ottawa, Ontario, K1A 0K2Canada
- Contracting authority
- Alan Escobedo Fox
- Email
- Alan.escobedofox@forces.gc.ca
Bidding details
| Document title | Amendment no. | Language | Unique downloads | Date added |
|---|---|---|---|---|
| ACAN - W6369-26-A112 - HI-6 DMS and Atropine RAD Feasibility Assessment.pdf | This document was removed on 2026/06/02 | |||
| PAC - W6369-26-A112 - Évaluation de faisabilité de DAR d'HI-6 DMS et de médicaments à base de sulfate d'atropine.pdf | This document was removed on 2026/06/02 | |||
| ACAN - W6369-26-A112 - HI-6 DMS and Atropine RAD Feasibility Assessment.pdf | 002 | EN | 13 | 2026/06/02 |
| PAC - W6369-26-A112 - Évaluation de faisabilité de DAR d'HI-6 DMS et de médicaments à base de sulfate d'atropine.pdf | 002 | FR | 2 | 2026/06/02 |
Eligibility and terms and conditions
Government of Canada tender and awards notices, solicitation documents, and other attachments are fully accessible and available free of charge and without having to register on CanadaBuys.
Information may be available on another source prior to being available on CanadaBuys. You may have received this information through a third-party distributor. The Government of Canada is not responsible for any tender notices and/or related documents and attachments not accessed directly from CanadaBuys.canada.ca.
Government of Canada tender or award notices carry an OpenGovernment License - Canada that governs its use. Related solicitation documents and/or tender attachments are copyright protected. Please refer to our terms and conditions page for more information.
